The HESI Genetic Toxicology Technical Committee (GTTC) applies their systematic and flexible approach for assessing the risk of genetic damage due to exposure to chemical substances to etoposide, a drug used in certain types of cancer treatments, as a representative pharmaceutical case study.
Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide
Environmental and Molecular Mutagenesis, 2021